Review decisions
Showing 6 results of 6 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1697728420996
Product Type: Drug
Control Number: 265427
DIN(s): 02475200, 02475219
Manufacturer: AstraZeneca Canada Inc
Submission Type: Supplement to a New Drug Submission - Notice of Compliance with Conditions
Date Filed / Submission Date: 2022-06-22
Decision / Authorization Date: 2023-07-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00989
Product Type: Drug
Control Number: 259417
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission - Notice of Compliance with Conditions
Date Filed / Submission Date: 2021-12-09
Decision / Authorization Date: 2022-07-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00399
Product Type: Drug
Control Number: 210204
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2017-10-13
Decision / Authorization Date: 2018-05-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00398
Product Type: Drug
Control Number: 205344
DIN(s): 02475200, 02475219
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2017-05-05
Decision / Authorization Date: 2018-05-04
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00130
Product Type: Drug
Control Number: 182823
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2015-03-16
Decision / Authorization Date: 2016-04-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00292
Product Type: Drug
Control Number: 182823
DIN(s): 02475200, 02475219
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2015-03-16
Issued / Original Publication Date: 2016-07-12
Decision / Authorization Date: 2016-04-29
Updated Date: 2025-07-31